Ads
related to: edwards resilia valve- TAVR Valves
Your valve choice matters.
Read about TAVR valve options.
- Important Risk Info
Read important risk information
about TAVR by Edwards
- Treatment Options
Learn about your treatment options
for SAS with symptoms.
- Watch Patient Videos
Meet patients who treated
their severe aortic stenosis.
- Hear From TAVR Patients
See stories of patients treated
with TAVR.
- Join Heart Valve Strong
Stay informed on the latest
about heart valve failure.
- TAVR Valves
Search results
Results From The WOW.Com Content Network
Investors are optimistic about Edwards Lifesciences' (EW) strong segmental performance and the growing demand for its RESILIA tissue valves.
Edwards Lifesciences' (EW) MITRIS RESILIA valve has been designed to resemble the appearance and function of the native mitral valve.
Edwards Lifesciences' (EW) SAPIEN 3 Ultra RESILIA valve combines its breakthrough RESILIA tissue technology with the SAPIEN 3 Ultra transcatheter aortic heart valve.
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the SAPIEN transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter . [ 4 ]
The Hancock Aortic Tissue Valve is commonly used in patients requiring aortic valve replacement due to conditions such as aortic stenosis or aortic regurgitation. [7] The choice between a mechanical or bioprosthetic valve depends on various factors, including the patient's age, lifestyle, and medical history.
Aortic valve replacement is a cardiac surgery procedure whereby a failing aortic valve is replaced with an artificial heart valve. The aortic valve may need to be replaced because of aortic regurgitation (back flow), or if the valve is narrowed by stenosis .
For premium support please call: 800-290-4726 more ways to reach us
The company was purchased by Edwards Lifesciences in 2004; its valve became the Sapien valve. [ 31 ] [ 32 ] It was the first aortic valve device to receive FDA approval, in November 2011 for use in inoperable patients and in October 2012 for use in patients at high surgical risk. [ 33 ]
Ad
related to: edwards resilia valve